205 related articles for article (PubMed ID: 33068555)
1. Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-Analysis.
Whitehurst TS; Osugo M; Townsend L; Shatalina E; Vava R; Onwordi EC; Howes O
Neurosci Biobehav Rev; 2020 Dec; 119():255-267. PubMed ID: 33068555
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy of N-acetyl aspartate in first depressive episode and chronic major depressive disorder: A systematic review and meta-analysis.
Saccaro LF; Tassone M; Tozzi F; Rutigliano G
J Affect Disord; 2024 Jun; 355():265-282. PubMed ID: 38554884
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis.
Brugger S; Davis JM; Leucht S; Stone JM
Biol Psychiatry; 2011 Mar; 69(5):495-503. PubMed ID: 21145039
[TBL] [Abstract][Full Text] [Related]
4. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
[TBL] [Abstract][Full Text] [Related]
5. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
[TBL] [Abstract][Full Text] [Related]
6. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
[TBL] [Abstract][Full Text] [Related]
7. Schizophrenia, temporal lobe epilepsy and psychosis: an in vivo magnetic resonance spectroscopy and imaging study of the hippocampus/amygdala complex.
Maier M; Mellers J; Toone B; Trimble M; Ron MA
Psychol Med; 2000 May; 30(3):571-81. PubMed ID: 10883713
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.
Wood SJ; Berger G; Velakoulis D; Phillips LJ; McGorry PD; Yung AR; Desmond P; Pantelis C
Schizophr Bull; 2003; 29(4):831-43. PubMed ID: 14989417
[TBL] [Abstract][Full Text] [Related]
9. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
[TBL] [Abstract][Full Text] [Related]
10. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients].
Başoğlu C; Cetin M; Oner O; Ebrinç S; Semiz UB; Kandilcioğlu H; Silit E; Kizilkaya E
Turk Psikiyatri Derg; 2006; 17(2):85-91. PubMed ID: 16755408
[TBL] [Abstract][Full Text] [Related]
12. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M
Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516
[TBL] [Abstract][Full Text] [Related]
14. [Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia].
Jia YB; Wang Y; Ling XY; Zhong SM; Huang L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):374-8. PubMed ID: 22445987
[TBL] [Abstract][Full Text] [Related]
15. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis.
Renshaw PF; Yurgelun-Todd DA; Tohen M; Gruber S; Cohen BM
Am J Psychiatry; 1995 Mar; 152(3):444-6. PubMed ID: 7864274
[TBL] [Abstract][Full Text] [Related]
16. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N
Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760
[TBL] [Abstract][Full Text] [Related]
17. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.
Block W; Bayer TA; Tepest R; Träber F; Rietschel M; Müller DJ; Schulze TG; Honer WG; Maier W; Schild HH; Falkai P
Neurosci Lett; 2000 Aug; 289(2):147-51. PubMed ID: 10904141
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
19. Findings of proton magnetic resonance spectometry in the dorsolateral prefrontal cortex in adolescents with first episodes of psychosis.
Zabala A; Sánchez-González J; Parellada M; Moreno DM; Reig S; Burdalo MT; Robles O; Desco M; Arango C
Psychiatry Res; 2007 Oct; 156(1):33-42. PubMed ID: 17764911
[TBL] [Abstract][Full Text] [Related]
20. Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of
Iwata Y; Nakajima S; Plitman E; Mihashi Y; Caravaggio F; Chung JK; Kim J; Gerretsen P; Mimura M; Remington G; Graff-Guerrero A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():340-352. PubMed ID: 29580804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
